{"id":"W4376613526","doi":"10.1016/j.esmoop.2023.101342","title":"118P Real-world treatment patterns and clinical outcomes among high risk, early stage HER2-negative breast cancer (BC) patients in Alberta, Canada","year":2023,"lang":"en","type":"article","venue":"ESMO Open","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada); University of Calgary","funders":"Chinese Academy of Medical Sciences; AstraZeneca; Les Laboratories Pierre Fabre; Academy of Medical Sciences; Chinese Academy of Sciences; Cancer Research Institute","keywords":"Medicine; Breast cancer; Cumulative incidence; Stage (stratigraphy); Population; Internal medicine; Cancer registry; Epidemiology; Hormone therapy; Incidence (geometry); Oncology; Adjuvant therapy; Cohort; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":true,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":true,"confidence":"low","status":"direct model label, unvalidated"}],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001032263,0.0002708457,0.0003943703,0.00004308501,0.0001253638,0.00004544651,0.0002268298,0.00007839206,0.00007178178],"category_scores_gemma":[0.00003675565,0.0002158805,0.00006439339,0.0001407482,0.00008754688,0.00001360231,0.000406307,0.00009733646,0.000007716581],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002521444,"about_ca_system_score_gemma":0.0002437905,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9999215,"about_ca_topic_score_gemma":0.9999548,"domain_scores_codex":[0.9984632,0.0001542463,0.000321959,0.0005735307,0.0001441763,0.0003429183],"domain_scores_gemma":[0.9991999,0.0001327644,0.0001608998,0.0003277002,0.00005400971,0.0001247077],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001468564,0.0001371996,0.9942961,0.000005093056,0.0004604242,0.00001811188,0.0001618994,0.0000113521,3.135175e-8,0.000005517239,0.001261136,0.003496286],"study_design_scores_gemma":[0.002912655,0.0001540026,0.9952949,0.00003054392,0.00006433894,2.570474e-7,0.0001159587,0.000003891144,0.0001134068,0.00001046286,0.001069515,0.0002300141],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965265,0.00000175479,2.429271e-7,0.0006900311,0.0002490435,0.0006004798,0.001417628,0.000008225814,0.0005060274],"genre_scores_gemma":[0.9924137,0.001651627,0.00001587178,0.0001476004,0.0000697189,0.0002895635,0.0002842227,0.0000327268,0.005094967],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00458894,"threshold_uncertainty_score":0.880335,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.015835592691497,"score_gpt":0.3128743880217857,"score_spread":0.2970387953302888,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}